Revolutionising Breast Cancer Care: How health managers can leverage REBECCA to improve patient outcomes

In the field of breast cancer care, REBECCA is a groundbreaking project that has the potential to revolutionalise the way we approach clinical research and patient care. Healthcare managers strive to procure the necessary tools, create the conditions and build the most optimal processes for the best possible care provision. The REBECCA system is definitely an option to consider for their mission. Health managers play a critical role in providing guidance and leadership to administer health at individual, organisational and systemic levels. They work closely with different stakeholders to create a clear health vision and alignment strategy, as well as to lay down the organisational, societal, and technological conditions required to achieve optimal health outcomes for individual patients and the entire community.

The adoption of the REBECCA system has the potential to offer numerous benefits to health managers. Firstly, the use of the REBECCA platform can improve clinical workflows and enhance interactions between health professionals and breast cancer patients. REBECCA is combining clinical data with real-life patient behaviour data to provide insights into the functional and emotional status of patients. This data is then summarised in an easy-to-use clinical dashboard that can help health professionals effectively monitor breast cancer patients and survivors and provide them with personalised post-treatment plans. This will allow patients to benefit from improved care and better management of the complex adverse effects that often result from breast cancer treatment, thus leading to faster recovery and better quality of life. Moreover, the dashboard also displays patient-reported outcomes measures (PROMs) that can provide valuable insights into how patients perceive their health and the quality of care they receive. PROMs will allow health managers to evaluate the effectiveness of cancer treatments and post-treatment interventions from the patient’s perspective, which is an essential component of patient-centred care.

Additionally, REBECCA will produce a list of best practices on post-cancer treatment emerging from the use of multisource real-world data. These best practices can be adopted and implemented in existing and future clinical workflows by health managers and health professionals to get a better understanding of the interdependence of breast cancer comorbidities, such as breast cancer treatment-induced peripheral neuropathy, breast cancer-related fatigue, and adjuvant treatment-induced osteopenia/osteoporosis. Health managers can also utilise  the scientific outcomes of REBECCA to ensure that the cancer treatments they apply are based on state-of-the-art knowledge.

Lastly, the REBECCA system can lead to increased efficiency at  health system level. In fact, the REBECCA system can help health managers to identify areas where breast cancer patients may be experiencing difficulties in their care pathway, and develop targeted interventions to address these issues. By streamlining clinical workflows and ensuring timely access to personalised treatment plans, the REBECCA system can help to optimise the use of available resources, increase efficiency, improve patient satisfaction and engagement, and ultimately lead to better patient outcomes.

In conclusion, the REBECCA system offers numerous benefits to health managers, making it a valuable tool in their efforts to enhance patient outcomes and transform healthcare delivery in the field of breast cancer.